首页> 外文期刊>Journal of gastroenterology and hepatology >Rapid on-site evaluation by endosonographer during endoscopic ultrasound-guided fine needle aspiration for pancreatic solid masses
【24h】

Rapid on-site evaluation by endosonographer during endoscopic ultrasound-guided fine needle aspiration for pancreatic solid masses

机译:超声内镜引导下细针穿刺术对胰腺实性肿块进行超声内镜快速现场评估

获取原文
获取原文并翻译 | 示例
       

摘要

Background and Aim: Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is an established diagnostic method for patients with suspected pancreatic ductal carcinoma. Rapid on-site evaluation (ROSE) has been reported to improve the accuracy. However, an on-site cytopathologist is not routinely available in many institutions. One of the solutions may be ROSE by endosonographer. The aim was to examine whether diagnostic accuracy increases through ROSE by endosonographer using our cytological criteria. Methods: Patients who underwent EUS-FNA of solid pancreatic masses from January 2006 to August 2009 (n=53, period 1) and September 2009 to April 2011 (n=85, period 2) were retrospectively identified. Before initiating ROSE at the start of period 2, two endosonographers underwent training for cytological interpretation, which was focused on four cytological features of pancreatic ductal carcinoma: anisonucleosis, nuclear membrane irregularity, overlapping, and enlargement. During EUS-FNA in period 2, endosonographers classified the Diff-Quik smears under three atypical grades and evaluated the adequacy. All diagnoses were made by one pathologist without knowledge of clinical information. Results: The rate of "inconclusive" diagnoses, interpreted as "suspicious," "atypical," and "inadequate for diagnosis" was reduced from 26.4% in period 1 to 8.2% in period 2 (P=0.004). Moreover, diagnostic accuracy was increased from 69.2% in period 1 to 91.8% in period 2 (P<0.001). Conclusions: This cytological grading system used in ROSE by endosonographers is invaluable for the diagnosis of pancreatic solid masses. ? 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.
机译:背景与目的:内镜超声引导下细针穿刺术(EUS-FNA)是一种可疑的胰腺导管癌患者的既定诊断方法。据报道,快速现场评估(ROSE)可提高准确性。但是,在许多机构中通常没有现场的细胞病理学家。解决方案之一可能是超声内窥镜检查员的ROSE。目的是通过超声检查,使用我们的细胞学标准检查通过ROSE的诊断准确性是否提高。方法:回顾性分析2006年1月至2009年8月(n = 53,第1期)和2009年9月至2011年4月(n = 85,第2期)接受实体胰腺肿块EUS-FNA的患者。在第2期开始时启动ROSE之前,两名内窥镜检查人员接受了细胞学解释训练,重点是胰腺导管癌的四个细胞学特征:异核症,核膜不规则,重叠和肿大。在第2阶段的EUS-FNA中,超声内窥镜检查人员将Diff-Quik涂片分为三个非典型等级,并评估了其适当性。所有诊断均由一名病理学家在不了解临床信息的情况下进行。结果:被解释为“可疑”,“非典型”和“不足以诊断”的“不确定性”诊断率从第1阶段的26.4%降至第2阶段的8.2%(P = 0.004)。此外,诊断准确性从第1阶段的69.2%提高到第2阶段的91.8%(P <0.001)。结论:内镜检查员在ROSE中使用的这种细胞学分级系统对于诊断胰腺实性肿块具有重要价值。 ? 2013年《胃肠病和肝病学杂志》和Wiley Publishing Asia Pty Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号